Exercise may fix blood vessels in obesity, study hints
NCT ID NCT04087655
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how exercise improves blood vessel function in people with obesity. Researchers will measure oxidative stress and blood flow in the muscle before and after an 8-week interval training program. The goal is to understand the role of a specific enzyme (NADPH oxidase) in causing blood vessel problems. 25 sedentary obese adults with metabolic syndrome will participate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- interval exercise training
- What this could lead to
- If successful, this study could reveal exactly how exercise improves blood vessel health in obesity, pointing toward better exercise-based treatments.
- What could go wrong
- This is a small, early-stage study (25 people) focused on understanding mechanisms, not testing a new treatment. Results may not apply to all obese individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Florida State University
RECRUITINGTallahassee, Florida, 32306, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test